ABT ▲ +1.5% - Abbott Laboratories
$ABT - Abbott initiates pivotal trial for Cephea™ device, an innovative treatment for mitral heart valve disease
29-OCT-2026 09:03 AM ET
Share this post
More filings for $ABT
ABT ▲ +0.0% - Abbott LaboratoriesOct 26, 2026ABT ▼ -0.4% - Abbott LaboratoriesOct 23, 2026ABT ▼ -3.4% - Abbott LaboratoriesOct 21, 2026ABT ▼ -1.6% - Abbott LaboratoriesOct 21, 2026ABT ▼ -1.6% - Abbott LaboratoriesOct 21, 2026ABT ▼ -1.6% - Abbott LaboratoriesOct 21, 2026
View full $ABT filing history →💬 Comments
Loading comments…
Leave a comment